Skip to main content

Month: April 2021

Emerging Markets Report: What’s In a Name?

An Emerging Markets Sponsored Commentary ORLANDO, Fla., April 15, 2021 (GLOBE NEWSWIRE) — A very strong hire for Legion Capital Corp (OTCQX: LGCP), a FinTech enabled private equity firm, as it adds a very big name in surname alone to its leadership team. In a release last week, the Company reported that the appointment of J. Bradley Hilton as the company’s Chief Technology Officer. Mr. Hilton is the grandson of iconic American Hotelier Conrad N. Hilton, who is considered one of the greatest American entrepreneurs in history. But Mr. Hilton brings more than just the family name of one of the world’s leading brands. J. Bradley’s background includes substantial technical, management, and executive experience in working with growing companies. As the former director of Hilton Hotels Corporation Information Technology Group, Mr....

Continue reading

Woodworking Machinery Market to Hit USD 6.05 Billion by 2028; Increasing Adoption of Precision Engineering to Favor Growth: Fortune Business Insights™

Pune, India, April 15, 2021 (GLOBE NEWSWIRE) — The global woodworking machinery market size is expected to experience exponential growth by reaching USD 6.05 billion by 2028 while exhibiting a CAGR of 3.9% between 2021 and 2028. This information is published by Fortune Business Insights in its latest report, titled, “Woodworking Machinery Market, 2021-2028.” The report further mentions that the market stood at USD 4.53 billion in 2020. Factors such as the increasing adoption of precision engineering is expected to boost the adoption of advanced woodworking machinery globally. For instance, in 2019, Biesse Group automated its 5-axis heads, a woodworking machine in its production line, to significantly reduce travel time and improve the machine precision on assembly lines. Request To Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/woodworking-machinery-market-105106 COVID-19...

Continue reading

Reata Announces the Appointments of Christy J. Oliger and Shamim Ruff to Its Board of Directors

PLANO, Texas, April 15, 2021 (GLOBE NEWSWIRE) — Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” or “we”), a clinical-stage biopharmaceutical company, today announced the appointments of Christy J. Oliger and Shamim Ruff to its Board of Directors, effective April 15, 2021. “We are excited to welcome Ms. Ruff and Ms. Oliger to Reata’s board,” said Warren Huff, Reata’s Chief Executive Officer and President. “They join at a critical point in Reata’s development having just submitted our first New Drug Application for bardoxolone methyl (“bardoxolone”) for the treatment of chronic kidney disease caused by Alport syndrome. Both Ms. Ruff and Ms. Oliger bring a wealth of experience that will be invaluable in helping us achieve our mission to develop innovative therapies that change patients’ lives for the better.” Ms....

Continue reading

Talenom vahvistaa liiketoimintaansa yhdistysten taloushallinnossa ostamalla Balance-Team Oy:n ja nostaa liikevaihto-ohjeistustaan

Talenom Oyj    Sisäpiiritieto    15.4.2021 kello 13.30 Talenom vahvistaa liiketoimintaansa yhdistysten taloushallinnossa ostamalla Balance-Team Oy:n ja nostaa liikevaihto-ohjeistustaan Talenom Oyj on ostanut yhdistysten taloushallintoon erikoistuneen Balance-Team Oy:n Helsingissä. Talenomilla on jo ennestään yhdistyksiin ja säätiöihin keskittynyt liiketoimintayksikkö, joka Balance-Team Oy:n oston myötä tekee Talenomista Suomen johtavan toimijan yleishyödyllisten yhteisöjen taloushallinnon palveluntarjoajana. Balance-Team Oy:n osakekanta siirtyy Talenomin omistukseen 15.4.2021. Ostettu yhtiö on muodostettu 1.4.2021 jakautumisessa, jossa yhtiöstä erotettiin tilitoimistoliiketoimintaan kuulumattomat toiminnot ja omaisuuserät. Siirtyvän tilitoimistoliiketoiminnan liikevaihto 31.12.2020 päättyneellä tilikaudella oli 2,7 miljoonaa euroa (31.12.2019:...

Continue reading

Talenom strengthens its business in the financial management of associations by acquiring Balance-Team Oy and raises its net sales guidance 

Talenom Plc    Inside information    15 April 2021 at 13:30 EESTTalenom strengthens its business in the financial management of associations by acquiring Balance-Team Oy and raises its net sales guidance  Talenom Plc has acquired the Helsinki-based Balance-Team Oy, which specialises in financial management for associations. Talenom already has a business unit focused on associations and foundations, which, with the acquisition of Balance-Team Oy will make Talenom a leading provider of financial management services for nonprofit organisations in Finland. The share capital of Balance-Team Oy will be transferred to Talenom on 15 April 2021. The acquired company was formed on 1 April 2021 in a demerger in which non-accounting activities and assets were separated from the company. Net sales of the transferred accounting business for the financial...

Continue reading

Affimed Reports 2020 Financial Results and Highlights Recent Operational Progress

AFM13 monotherapy: Reported positive data from the preplanned interim analysis for the registration-directed trial in PTCL AFM13 combination with NK cells: Announced 100% objective response rate in four response evaluable patients, including 2 complete responses AFM24 monotherapy: AFM24 (phase 1/2a study) completed cohort 4 and is enrolling and treating patients in cohort 5; expansion cohorts expected to start in the second half of 2021 AFM24 combination with NK cells: IND application cleared by the FDA for the combination of AFM24 with NKGen Biotech’s SNK-01 NK autologous cell therapy AFM24 combination with anti PD-L1 antibody: Established a collaboration with Roche to clinically explore the combination of AFM24 with atezolizumab (Tecentriq®) Made continued progress in advancing and forming partnerships with Genentech and Roivant, which...

Continue reading

Teleflex Announces First Quarter 2021 Earnings Conference Call Information

WAYNE, Pa., April 15, 2021 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX) announced today that financial results for the first quarter 2021 will be released before market open on Thursday, April 29, 2021.  An investor conference call will be held at 8:00 a.m. (ET) on Thursday, April 29, 2021.  The call can be accessed through a live audio webcast on the company’s website, www.teleflex.com.  An audio replay of the call will also be available on the website from April 29, 2021 at 11:00 a.m. (ET) to May 6, 2021 at 11:59 p.m. (ET) by calling 800-585-8367 (U.S./Canada) or 416-621-4642 (International), Passcode: 6194708. About Teleflex IncorporatedTeleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying...

Continue reading

CENTOGENE Reports Record Fourth Quarter and Full Year 2020 Financial Results

Revenues more than doubled in FY 2020 compared to FY 2019 to a record €128.4 million, with Q4 2020 revenues nearly quadrupling year-over-year to a record €70.3 million Achieved highest annual adjusted EBITDA in CENTOGENE’s history, driven by COVID-19 testing revenues in H2 of 2020, even with continuous investment in the Company’s rare disease core business 100,000 patients added to rare disease-centric database and biobank in 2020, an increase of 20% Diagnostics recovery and newly signed Pharma partnership deals indicate a return to solid core business growth in 2021Virtual Investor Event outlining future strategy and direction of the Company to be held on June 22ndCAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, April 15, 2021 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG) (“CENTOGENE” or the “Company”), a commercial-stage...

Continue reading

Life Clips, Inc. Subsidiary Cognitive Apps Recognized as One of the Most Promising AI Startups in the Healthcare and Technology Space

AVENTURA, Fla., April 15, 2021 (GLOBE NEWSWIRE) — Life Clips, Inc. (OTC Pink: LCLP) (the “Company”) today announced that its subsidiary Cognitive Apps Software recently participated in the February 2021 Y Combinator cohort receiving an award as one of the most promising Artificial Intelligence (AI) startups in the space of healthcare and technology. This success has further validated Cognitive Apps proof of concept and has energized the entire Cognitive Apps team and motivated us to push the boundaries of innovation in the space of AI. Following this success, Cognitive Apps is developing a series of new features rolling out in coming weeks including speech to text for clinical documentation purposes in the healthcare and a series of intuitive chat bots targeting various mental health care indications. Additionally, Cognitive Apps...

Continue reading

TILT Holdings Reports Fourth Quarter and Full-Year 2020 Financial Results Including First Full-Year of Positive Adjusted EBITDA

Full-year 2020 Adjusted EBITDA of $16.9 million compared to Adjusted EBITDA loss of $0.8 million in 2019 Full-year 2020 cash from operating activities improved $34.2 million compared to 2019 Full-year 2020 cannabis revenue increased 41% compared to 2019 Full-year cash expenses decreased 30% compared to 2019 PHOENIX, April 15, 2021 (GLOBE NEWSWIRE) — TILT Holdings Inc. (“TILT” or the “Company”) (CSE: TILT) (OTCQB: TLLTF) a provider of business solutions to the global cannabis industry that includes inhalation technologies, cultivation, manufacturing, processing, brand development and retail, reported its financial and operating results for the three and twelve-months ended December 31, 2020. All financial information is provided in U.S. dollars except where otherwise indicated. Results of Yaris Acquisition, LLC and its subsidiaries...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.